Skip to content
1887

Abstract

Invasive infections caused by the important pathogen are often associated with disturbed blood coagulation in the human host, and may in severe cases develop into the life-threatening condition disseminated intravascular coagulation. In this study, the addition of M1 protein to human blood or purified peripheral blood mononuclear cells led to a dose-dependent increase of pro-coagulant activity, which was mediated by an upregulation of tissue factor on monocytes. Analysis of the resulting clots by transmission electron microscopy revealed that the cells were covered with a fibrin network that seemed to originate from the cell surface. Taken together, the results imply an important role for M proteins in the induction of haemostatic disorders in invasive streptococcal infectious diseases.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.2006/003285-0
2007-08-01
2025-02-12
Loading full text...

Full text loading...

/deliver/fulltext/micro/153/8/2458.html?itemId=/content/journal/micro/10.1099/mic.0.2006/003285-0&mimeType=html&fmt=ahah

References

  1. Abraham E., Reinhart K., Opal S., Demeyer I., Doig C., Rodriguez A. L., Beale R., Svoboda P., Laterre P. F. other authors 2003; Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 290:238–247
    [Google Scholar]
  2. Åkesson P., Schmidt K. H., Cooney J., Björck L. 1994; M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes. Biochem J 300:877–886
    [Google Scholar]
  3. Beres S. B., Richter E. W., Nagiec M. J., Sumby P., Porcella S. F., Deleo F. R., Musser J. M. 2006; Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus . Proc Natl Acad Sci U S A 103:7059–7064
    [Google Scholar]
  4. Berge A., Björck L. 1995; Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 270:9862–9867
    [Google Scholar]
  5. Bisno A. L., Brito M. O., Collins C. M. 2003; Molecular basis of group A streptococcal virulence. Lancet Infect Dis 3:191–200
    [Google Scholar]
  6. Bryant A. E., Hayes-Schroer S. M., Stevens D. L. 2003; M type 1 and 3 group A streptococci stimulate tissue factor-mediated procoagulant activity in human monocytes and endothelial cells. Infect Immun 71:1903–1910
    [Google Scholar]
  7. Camerer E., Huang W., Coughlin S. R. 2000; Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A 97:5255–5260
    [Google Scholar]
  8. Camerer E., Kataoka H., Kahn M., Lease K., Coughlin S. R. 2002; Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells. J Biol Chem 277:16081–16087
    [Google Scholar]
  9. Carapetis J. R., Steer A. C., Mulholland E. K., Weber M. 2005; The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685–694
    [Google Scholar]
  10. Collin M., Olsén A. 2000; Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein. Mol Microbiol 36:1306–1318
    [Google Scholar]
  11. Creasey A. A., Chang A. C., Feigen L., Wun T. C., Taylor F. B. Jr, Hinshaw L. B. 1993; Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 91:2850–2860
    [Google Scholar]
  12. Cunningham M. A., Romas P., Hutchinson P., Holdsworth S. R., Tipping P. G. 1999; Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood 94:3413–3420
    [Google Scholar]
  13. Cunningham M. W. 2000; Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13:470–511
    [Google Scholar]
  14. de Chateau M., Björck L. 1994; Protein PAB, a mosaic albumin-binding bacterial protein representing the first contemporary example of module shuffling. J Biol Chem 269:12147–12151
    [Google Scholar]
  15. Doshi S. N., Marmur J. D. 2002; Evolving role of tissue factor and its pathway inhibitor. Crit Care Med 30:S241–S250
    [Google Scholar]
  16. Fischetti V. A. 1989; Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 2:285–314
    [Google Scholar]
  17. Guha M., O'Connell M. A., Pawlinski R., Hollis A., McGovern P., Yan S. F., Stern D., Mackman N. 2001; Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98:1429–1439
    [Google Scholar]
  18. Herwald H., Cramer H., Mörgelin M., Russell W., Sollenberg U., Norrby-Teglund A., Flodgaard H., Lindbom L., Björck L. 2004; M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 116:367–379
    [Google Scholar]
  19. Kastern W., Sjöbring U., Björck L. 1992; Structure of peptostreptococcal protein L and identification of a repeated immunoglobulin light chain-binding domain. J Biol Chem 267:12820–12825
    [Google Scholar]
  20. Kihlberg B. M., Cooney J., Caparon M. G., Olsén A., Björck L. 1995; Biological properties of a Streptococcus pyogenes mutant generated by Tn 916 insertion in mga . Microb Pathog 19:299–315
    [Google Scholar]
  21. Kotb M., Norrby-Teglund A., McGeer A., El-Sherbini H., Dorak M. T., Khurshid A., Green K., Peeples J., Wade J. other authors 2002; An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 8:1398–1404
    [Google Scholar]
  22. Lancefield R. C. 1969; Current problems in studies of streptococci. J Gen Microbiol 55:161–163
    [Google Scholar]
  23. Levi M., de Jonge E., van der Poll T. 2003; Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis 16:43–47
    [Google Scholar]
  24. Loken M. R., Brosnan J. M., Bach B. A., Ault K. A. 1990; Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 11:453–459
    [Google Scholar]
  25. Mackman N. 2006; Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol Dis 36:104–107
    [Google Scholar]
  26. Opal S. M., Esmon C. T. 2003; Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 7:23–38
    [Google Scholar]
  27. Påhlman L. I., Mörgelin M., Eckert J., Johansson L., Russell W., Riesbeck K., Soehnlein O., Lindbom L., Norrby-Teglund A. other authors 2006; Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol 177:1221–1228
    [Google Scholar]
  28. Pawlinski R., Pedersen B., Schabbauer G., Tencati M., Holscher T., Boisvert W., Andrade-Gordon P., Frank R. D., Mackman N. 2004; Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 103:1342–1347
    [Google Scholar]
  29. Price G. C., Thompson S. A., Kam P. C. 2004; Tissue factor and tissue factor pathway inhibitor. Anaesthesia 59:483–492
    [Google Scholar]
  30. Riedemann N. C., Guo R. F., Ward P. A. 2003; Novel strategies for the treatment of sepsis. Nat Med 9:517–524
    [Google Scholar]
  31. Roeder A., Kirschning C. J., Schaller M., Weindl G., Wagner H., Korting H. C., Rupec R. A. 2004; Induction of nuclear factor- κ B and c-Jun/activator protein-1 via Toll-like receptor 2 in macrophages by antimycotic-treated Candida albicans . J Infect Dis 190:1318–1326
    [Google Scholar]
  32. Stevens D. L. 1992; Invasive group A Streptococcus infections. Clin Infect Dis 14:2–11
    [Google Scholar]
  33. Stevens D. L. 2003; Group A streptococcal sepsis. Curr Infect Dis Rep 5:379–386
    [Google Scholar]
  34. Sutherland A. M., Walley K. R., Russell J. A. 2005; Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 33:638–644
    [Google Scholar]
  35. Taylor F. B., Chang A. C., Peer G., Li A., Ezban M., Hedner U. 1998; Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli . Blood 91:1609–1615
    [Google Scholar]
  36. Van Amersfoort E. S., Van Berkel T. J., Kuiper J. 2003; Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 16:379–414
    [Google Scholar]
  37. Weineisen M., Sjöbring U., Fallman M., Andersson T. 2004; Streptococcal M5 protein prevents neutrophil phagocytosis by interfering with CD11b/CD18 receptor-mediated association and signaling. J Immunol 172:3798–3807
    [Google Scholar]
/content/journal/micro/10.1099/mic.0.2006/003285-0
Loading
/content/journal/micro/10.1099/mic.0.2006/003285-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error